{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:02:17Z","timestamp":1792119737887,"version":"4.4.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ejpb.2022.08.004","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:45:46Z","timestamp":1661301946000},"page":"11-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Biodistribution and toxicity of innate defense regulator 1018 (IDR-1018)"],"prefix":"10.1016","volume":"179","author":[{"given":"Tullio V.F.","family":"Esposito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Rodr\u00edguez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Blackadar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan F.","family":"Haney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pletzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.W.","family":"Hancock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katayoun","family":"Saatchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs O.","family":"H\u00e4feli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2022.08.004_b0005","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/415389a","article-title":"Antimicrobial peptides of multicellular organisms","volume":"415","author":"Zasloff","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2022.08.004_b0010","doi-asserted-by":"crossref","unstructured":"E.F. Haney, S.C. Mansour, R.E.W. Hancock, Antimicrobial Peptides: An Introduction, in: P.R. Hansen (Ed.) Antimicrobial Peptides: Methods and Protocols, Springer New York, New York, NY, 2017, pp. 3\u201322.","DOI":"10.1007\/978-1-4939-6737-7_1"},{"key":"10.1016\/j.ejpb.2022.08.004_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2019.00043","article-title":"Reassessing the host defense peptide landscape","volume":"7","author":"Haney","year":"2019","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejpb.2022.08.004_b0020","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/psc.2708","article-title":"Peptide IDR-1018: modulating the immune system and targeting bacterial biofilms to treat antibiotic-resistant bacterial infections","volume":"21","author":"Mansour","year":"2015","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.ejpb.2022.08.004_b0025","doi-asserted-by":"crossref","unstructured":"M. Wieczorek, H. Jenssen, J. Kindrachuk, W.R. Scott, M. Elliott, K. Hilpert, J.T. Cheng, R.E. Hancock, S.K. Straus, Structural studies of a peptide with immune modulating and direct antimicrobial activity, Chem. Biol. (Oxford, U. K.), 17 (2010) 970\u2013980.","DOI":"10.1016\/j.chembiol.2010.07.007"},{"key":"10.1016\/j.ejpb.2022.08.004_b0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1189\/jlb.1012497","article-title":"The innate defense regulator peptides IDR-HH2, IDR-1002, and IDR-1018 modulate human neutrophil functions","volume":"94","author":"Niyonsaba","year":"2013","journal-title":"J. Leukocyte Biol."},{"key":"10.1016\/j.ejpb.2022.08.004_b0035","doi-asserted-by":"crossref","first-page":"e52449","DOI":"10.1371\/journal.pone.0052449","article-title":"Synthetic cationic peptide IDR-1018 modulates human macrophage differentiation","volume":"8","author":"Pena","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2022.08.004_b0040","doi-asserted-by":"crossref","first-page":"e1004152","DOI":"10.1371\/journal.ppat.1004152","article-title":"Broad-spectrum anti-biofilm peptide that targets a cellular stress response","volume":"10","author":"de la Fuente-N\u00fa\u00f1ez","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejpb.2022.08.004_b0045","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ana.24087","article-title":"Innate defense regulator peptide 1018 protects against perinatal brain injury","volume":"75","author":"Bolouri","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejpb.2022.08.004_b0050","doi-asserted-by":"crossref","first-page":"135ra164","DOI":"10.1126\/scitranslmed.3003515","article-title":"Effective adjunctive therapy by an innate defense regulatory peptide in a preclinical model of severe malaria","volume":"4","author":"Achtman","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejpb.2022.08.004_b0055","doi-asserted-by":"crossref","unstructured":"B. Rivas-Santiago, J.E. Casta\u00f1eda-Delgado, C.E. Rivas Santiago, M. Waldbrook, I. Gonz\u00e1lez-Curiel, J.C. Le\u00f3n-Contreras, J.A. Enciso-Moreno, V.d. Villar, J. Mendez-Ramos, R.E.W. Hancock, R. Hernandez-Pando, Ability of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against mycobacterium tuberculosis infections in animal models, PLOS ONE 8 (2013) e59119.","DOI":"10.1371\/journal.pone.0059119"},{"key":"10.1016\/j.ejpb.2022.08.004_b0060","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1007\/s11999-015-4301-2","article-title":"Immunomodulatory peptide IDR-1018 decreases implant infection and preserves osseointegration","volume":"473","author":"Choe","year":"2015","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.ejpb.2022.08.004_b0065","doi-asserted-by":"crossref","first-page":"e39373","DOI":"10.1371\/journal.pone.0039373","article-title":"Innate defense regulator peptide 1018 in wound healing and wound infection","volume":"7","author":"Steinstraesser","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2022.08.004_b0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.peptides.2018.01.010","article-title":"Induction by innate defence regulator peptide 1018 of pro-angiogenic molecules and endothelial cell migration in a high glucose environment","volume":"101","author":"Marin-Luevano","year":"2018","journal-title":"Peptides"},{"key":"10.1016\/j.ejpb.2022.08.004_b0075","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/term.2953","article-title":"IDR-1018 induces cell proliferation, migration, and reparative gene expression in 2D culture and 3D human skin equivalents","volume":"13","author":"Alencar-Silva","year":"2019","journal-title":"J. Tissue Eng. Regener. Med."},{"key":"10.1016\/j.ejpb.2022.08.004_b0080","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s12026-017-8932-0","article-title":"Innate defense regulator IDR-1018 activates human mast cells through g protein-, phospholipase C-, MAPK- and NF-\u0138B-sensitive pathways","volume":"65","author":"Yanashima","year":"2017","journal-title":"Immunol. Res."},{"key":"10.1016\/j.ejpb.2022.08.004_b0085","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3389\/fmicb.2017.01867","article-title":"Synthetic peptides to target stringent response-controlled virulence in a pseudomonas aeruginosa murine cutaneous infection model","volume":"8","author":"Pletzer","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejpb.2022.08.004_b0090","doi-asserted-by":"crossref","first-page":"e1007084","DOI":"10.1371\/journal.ppat.1007084","article-title":"Synergy between conventional antibiotics and anti-biofilm peptides in a murine, sub-cutaneous abscess model caused by recalcitrant ESKAPE pathogens","volume":"14","author":"Pletzer","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejpb.2022.08.004_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00726-019-02804-4","article-title":"Killing streptococcus mutans in mature biofilm with a combination of antimicrobial and antibiofilm peptides","volume":"52","author":"Cao","year":"2020","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejpb.2022.08.004_b0100","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/infdis\/jiaa778","article-title":"Contribution of swarming motility to dissemination in a pseudomonas aeruginosa murine skin abscess infection model","volume":"224","author":"Coleman","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejpb.2022.08.004_b0105","doi-asserted-by":"crossref","first-page":"e0250977","DOI":"10.1371\/journal.pone.0250977","article-title":"Peptide 1018 inhibits swarming and influences Anr-regulated gene expression downstream of the stringent stress response in Pseudomonas aeruginosa","volume":"16","author":"Wilkinson","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2022.08.004_b0110","doi-asserted-by":"crossref","first-page":"e24077","DOI":"10.1002\/pep2.24077","article-title":"Identification of an IDR peptide formulation candidate that prevents peptide aggregation and retains immunomodulatory activity","volume":"111","author":"Haney","year":"2019","journal-title":"Pept. Sci."},{"key":"10.1016\/j.ejpb.2022.08.004_b0115","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.chembiol.2017.07.010","article-title":"Aggregation and its influence on the immunomodulatory activity of synthetic innate defense regulator peptides","volume":"24","author":"Haney","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejpb.2022.08.004_b0120","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejpb.2022.08.004_b0125","doi-asserted-by":"crossref","first-page":"15726","DOI":"10.1021\/ja106399h","article-title":"Acyclic chelate with ideal properties for (68)Ga PET imaging agent elaboration","volume":"132","author":"Boros","year":"2010","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.ejpb.2022.08.004_b0130","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s002590050488","article-title":"Peptide radiopharmaceuticals in nuclear medicine","volume":"26","author":"Blok","year":"1999","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.ejpb.2022.08.004_b0135","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1021\/bc300037w","article-title":"Comparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro\/in vivo stability","volume":"23","author":"Cooper","year":"2012","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.ejpb.2022.08.004_b0140","first-page":"861","article-title":"New method for the chelation of indium-111 to monoclonal antibodies: biodistribution and imaging of athymic mice bearing human colon carcinoma xenografts","volume":"28","author":"Esteban","year":"1987","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejpb.2022.08.004_b0145","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1021\/bc200197h","article-title":"Comparison study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice","volume":"22","author":"Lang","year":"2011","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.ejpb.2022.08.004_b0150","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.nucmedbio.2020.11.003","article-title":"On the consensus nomenclature rules for radiopharmaceutical chemistry \u2013 Reconsideration of radiochemical conversion","volume":"93","author":"Herth","year":"2021","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejpb.2022.08.004_b0155","first-page":"1431","article-title":"Understanding the standardized uptake value its methods, and implications for usage","volume":"45","author":"Thie","year":"2004","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejpb.2022.08.004_b0160","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1152\/nips.01519.2004","article-title":"Morphological features of cell death","volume":"19","author":"Ziegler","year":"2004","journal-title":"Physiology"},{"key":"10.1016\/j.ejpb.2022.08.004_b0165","first-page":"2135","article-title":"Distribution of gallium-67 in normal and hypotransferrinemic tumor-bearing mice","volume":"34","author":"Sohn","year":"1993","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejpb.2022.08.004_b0170","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0031-6997(24)01383-8","article-title":"Mechanisms of therapeutic activity for gallium","volume":"50","author":"Bernstein","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejpb.2022.08.004_b0175","unstructured":"T.V.F. Esposito, Rodriguez-Rodriguez, C., Blackadar, C., Saatchi, K., Hafeli, U. O., Pharmacokinetics of the Host Defense Peptide LL-37 using SPECT\/CT, [In Preparation]."},{"key":"10.1016\/j.ejpb.2022.08.004_b0180","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1021\/bc900443a","article-title":"Evaluation of bifunctional chelates for the development of gallium-based radiopharmaceuticals","volume":"21","author":"Ferreira","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejpb.2022.08.004_b0185","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","article-title":"Antimicrobial host defence peptides: functions and clinical potential","volume":"19","author":"Mookherjee","year":"2020","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.ejpb.2022.08.004_b0190","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.coph.2006.04.006","article-title":"Antibacterial peptides for therapeutic use: obstacles and realistic outlook","volume":"6","author":"Marr","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejpb.2022.08.004_b0195","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.mib.2004.08.013","article-title":"Taking inventory: antibacterial agents currently at or beyond phase 1","volume":"7","author":"Bush","year":"2004","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejpb.2022.08.004_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24162987","article-title":"Replacement of l-amino acids by d-amino acids in the antimicrobial peptide ranalexin and its consequences for antimicrobial activity and biodistribution","volume":"24","author":"Domhan","year":"2019","journal-title":"Molecules (Basel Switzerland)"},{"key":"10.1016\/j.ejpb.2022.08.004_b0205","doi-asserted-by":"crossref","first-page":"3149249","DOI":"10.1155\/2019\/3149249","article-title":"Radiolabeled Cationic Peptides for Targeted Imaging of Infection","volume":"2019","author":"Aweda","year":"2019","journal-title":"Contrast Media Mol. Imaging"},{"key":"10.1016\/j.ejpb.2022.08.004_b0210","unstructured":"J. Yuan, X. You, G. Ni, T. Wang, S. Cavezza, X. Pan, X. Liu, Iodine-125 labeled Australian frog tree host-defense peptides caerin 1.1 and 1.9 better inhibit human breast cancer cells growth than the unlabeled peptides. (125)I-caerin 1.9 may better be used for the treatment of breast cancer, Hellenic J. Nucl. Med. 21 (2018) 115-120."},{"key":"10.1016\/j.ejpb.2022.08.004_b0215","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1172\/JCI38842","article-title":"Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth","volume":"119","author":"Soman","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejpb.2022.08.004_b0220","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1021\/acs.accounts.8b00624","article-title":"Very short and stable lactoferricin-derived antimicrobial peptides: design principles and potential uses","volume":"52","author":"Svendsen","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejpb.2022.08.004_b0225","doi-asserted-by":"crossref","first-page":"26077","DOI":"10.1038\/srep26077","article-title":"In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate","volume":"6","author":"Brunetti","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2022.08.004_b0230","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jpba.2019.01.046","article-title":"Liquid chromatography\u2013tandem mass spectrometry based method development and validation of S016\u20131271 (LR8P), a novel cationic antimicrobial peptide for its application to pharmacokinetic studies","volume":"169","author":"Puttrevu","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2022.08.004_b0235","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/jac\/dkp331","article-title":"Pharmacokinetics of novel antimicrobial cationic peptides NAB 7061 and NAB 739 in rats following intravenous administration","volume":"64","author":"Ali","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejpb.2022.08.004_b0240","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1741-7015-7-44","article-title":"Safety and tolerability of the antimicrobial peptide human lactoferrin 1\u201311 (hLF1-11)","volume":"7","author":"van der Velden","year":"2009","journal-title":"BMC Med."},{"key":"10.1016\/j.ejpb.2022.08.004_b0245","first-page":"2073","article-title":"Imaging of bacterial infections with 99mTc-labeled human neutrophil peptide-1, Journal of nuclear medicine : official publication","volume":"40","author":"Welling","year":"1999","journal-title":"Soc. Nucl. Med."},{"key":"10.1016\/j.ejpb.2022.08.004_b0250","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.peptides.2006.05.022","article-title":"Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice","volume":"27","author":"Brouwer","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.ejpb.2022.08.004_b0255","first-page":"567","article-title":"Antimicrobial peptide 99mTc-ubiquicidin 29\u201341 as human infection-imaging agent: clinical trial","volume":"46","author":"Akhtar","year":"2005","journal-title":"J. Nucl. Med.: Official Publ. Soc. Nucl. Med."},{"key":"10.1016\/j.ejpb.2022.08.004_b0260","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.1021\/acs.jmedchem.6b00144","article-title":"Proteolytically Stable foldamer mimics of host-defense peptides with protective activities in a murine model of bacterial infection","volume":"59","author":"Teyssi\u00e8res","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejpb.2022.08.004_b0265","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.peptides.2011.05.009","article-title":"Determination of a new antibacterial peptide S-thanatin in rat plasma by an indirected-ELISA","volume":"32","author":"Wu","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.ejpb.2022.08.004_b0270","doi-asserted-by":"crossref","unstructured":"V. Basso, D.Q. Tran, J.B. Schaal, P. Tran, Y. Eriguchi, D. Ngole, A.E. Cabebe, A.Y. Park, P.M. Beringer, A.J. Ouellette, M.E. Selsted, Rhesus theta defensin 1 promotes long term survival in systemic candidiasis by host directed mechanisms, Sci. Rep. 9 (2019) 16905\u201316905.","DOI":"10.1038\/s41598-019-53402-z"},{"key":"10.1016\/j.ejpb.2022.08.004_b0275","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/jac\/dkv454","article-title":"Pharmacokinetics and in vivo efficacy of optimized oncocin derivatives","volume":"71","author":"Schmidt","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"issue":"2009","key":"10.1016\/j.ejpb.2022.08.004_b0280","first-page":"113","article-title":"Stereological estimates of alveolar number and size and capillary length and surface area in mice lungs","volume":"292","author":"Knust","year":"2007","journal-title":"Anatomical. Rec. (Hoboken N.J.)"},{"key":"10.1016\/j.ejpb.2022.08.004_b0285","doi-asserted-by":"crossref","first-page":"6274","DOI":"10.1128\/AAC.00653-15","article-title":"Bactericidal activity of ceragenin CSA-13 in Cell culture and in an animal model of peritoneal infection","volume":"59","author":"Bucki","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejpb.2022.08.004_b0290","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1021\/jm0703542","article-title":"Albumin binding of short cationic antimicrobial micropeptides and its influence on the in vitro bactericidal effect","volume":"50","author":"Svenson","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejpb.2022.08.004_b0295","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/rcm.1361","article-title":"The antimicrobial peptide LL-37 binds to the human plasma protein apolipoprotein A-I","volume":"18","author":"Wang","year":"2004","journal-title":"Rapid Commun. Mass Spectrom.: RCM"},{"key":"10.1016\/j.ejpb.2022.08.004_b0300","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/IAI.73.1.583-591.2005","article-title":"Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells","volume":"73","author":"Lau","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejpb.2022.08.004_b0305","doi-asserted-by":"crossref","first-page":"36007","DOI":"10.1074\/jbc.C109.073627","article-title":"Sequestosome-1\/p62 is the key intracellular target of innate defense regulator peptide","volume":"284","author":"Yu","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"2010","key":"10.1016\/j.ejpb.2022.08.004_b0310","first-page":"2539","article-title":"Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment","volume":"184","author":"Nijnik","year":"1950","journal-title":"J. Immunol. (Baltimore Md.)"},{"key":"10.1016\/j.ejpb.2022.08.004_b0315","doi-asserted-by":"crossref","unstructured":"L. Steinstraesser, T. Hirsch, M. Schulte, M. Kueckelhaus, F. Jacobsen, E.A. Mersch, I. Stricker, N. Afacan, H. Jenssen, R.E.W. Hancock, J. Kindrachuk, Innate defense regulator peptide 1018 in wound healing and wound infection, PLoS One 7 (2012) e39373\u2013e39373.","DOI":"10.1371\/journal.pone.0039373"},{"key":"10.1016\/j.ejpb.2022.08.004_b0320","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.chembiol.2010.07.007","article-title":"Structural studies of a peptide with immune modulating and direct antimicrobial activity","volume":"17","author":"Wieczorek","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejpb.2022.08.004_b0325","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1189\/jlb.1005560","article-title":"The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system","volume":"80","author":"Barlow","year":"2006","journal-title":"J Leukoc. Biol."},{"key":"10.1016\/j.ejpb.2022.08.004_b0330","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00259-001-0760-7","article-title":"Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections","volume":"29","author":"Lupetti","year":"2002","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ejpb.2022.08.004_b0335","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.nucmedbio.2008.10.011","article-title":"Detection of sites of infection in mice using 99mTc-labeled PN(2)S-PEG conjugated to UBI and 99mTc-UBI: a comparative biodistribution study","volume":"36","author":"Mel\u00e9ndez-Alafort","year":"2009","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejpb.2022.08.004_b0340","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.nantod.2015.06.006","article-title":"Nanoparticle uptake: the phagocyte problem","volume":"10","author":"Gustafson","year":"2015","journal-title":"Nano Today"},{"key":"10.1016\/j.ejpb.2022.08.004_b0345","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2217\/nnm.10.23","article-title":"Understanding and overcoming major barriers in cancer nanomedicine","volume":"5","author":"Nie","year":"2010","journal-title":"Nanomedicine (London U.K.)"},{"key":"10.1016\/j.ejpb.2022.08.004_b0350","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/bit.21301","article-title":"Microparticles and nanoparticles for drug delivery","volume":"96","author":"Kohane","year":"2007","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.ejpb.2022.08.004_b0355","doi-asserted-by":"crossref","first-page":"12369","DOI":"10.1073\/pnas.0913667107","article-title":"Paradoxical glomerular filtration of carbon nanotubes","volume":"107","author":"Ruggiero","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejpb.2022.08.004_b0360","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nnano.2017.170","article-title":"Glomerular barrier behaves as an atomically precise bandpass filter in a sub-nanometre regime","volume":"12","author":"Du","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ejpb.2022.08.004_b0365","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cbpa.2008.03.019","article-title":"Blood\u2013brain barrier permeability considerations for CNS-targeted compound library design","volume":"12","author":"Hitchcock","year":"2008","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejpb.2022.08.004_b0370","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2174\/09298665113206660110","article-title":"Blood-brain barrier transport of short proline-rich antimicrobial peptides","volume":"21","author":"Stalmans","year":"2014","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.ejpb.2022.08.004_b0375","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s10096-001-0680-2","article-title":"Cerebrospinal fluid penetration and pharmacokinetic\/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis","volume":"21","author":"Jim\u00e9nez-Mej\u00edas","year":"2002","journal-title":"Euro. J. Clin. Microbiol. Infect. Diseases: Off. Publ. Euro. Soc. Clin. Microbiol."},{"key":"10.1016\/j.ejpb.2022.08.004_b0380","doi-asserted-by":"crossref","unstructured":"V.J. Quagliarello, W.M. Scheld, New perspectives on bacterial meningitis, Clin. Infect. Diseases: Off. Publ. Infect. Diseases Soc. Am. 17 (1993) 603\u2013608; quiz 609-610.","DOI":"10.1093\/clinids\/17.4.603"},{"key":"10.1016\/j.ejpb.2022.08.004_b0385","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nnano.2009.153","article-title":"Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent","volume":"4","author":"Liu","year":"2009","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ejpb.2022.08.004_b0390","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.616979","article-title":"Review: lessons learned from clinical trials using Antimicrobial Peptides (AMPs)","volume":"12","author":"Dijksteel","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejpb.2022.08.004_b0395","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1093\/jac\/dkq337","article-title":"Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infections","volume":"65","author":"Ostorhazi","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejpb.2022.08.004_b0400","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.2174\/092986709789352295","article-title":"The antibacterial effect of a proline-rich antibacterial peptide A3-APO","volume":"16","author":"Rozgonyi","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejpb.2022.08.004_b0405","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/jac\/dkx482","article-title":"Proline-rich antimicrobial peptides show a long-lasting post-antibiotic effect on Enterobacteriaceae and Pseudomonas aeruginosa","volume":"73","author":"Holfeld","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejpb.2022.08.004_b0410","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.02283","article-title":"Continuous subcutaneous delivery of proline-rich antimicrobial peptide Api137 provides superior efficacy to intravenous administration in a mouse infection model","author":"Knappe","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejpb.2022.08.004_b0415","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1021\/nl073290r","article-title":"Synthesis and characterization of stable fluorocarbon nanostructures as drug delivery vehicles for cytolytic peptides","volume":"8","author":"Soman","year":"2008","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejpb.2022.08.004_b0420","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF00170012","article-title":"The use of SEP-PAK SI cartridges for the preparation of gallium chloride from the citrate solution","volume":"20","author":"Scasnar","year":"1993","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.ejpb.2022.08.004_b0425","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2022.08.004_b0430","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2967\/jnumed.112.109538","article-title":"VECTor: a Preclinical imaging system for simultaneous submillimeter SPECT and PET","volume":"54","author":"Goorden","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejpb.2022.08.004_b0435","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2967\/jnumed.114.147140","article-title":"Ultra-high-sensitivity submillimeter mouse SPECT","volume":"56","author":"Ivashchenko","year":"2015","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejpb.2022.08.004_b0440","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1162\/153535003322556877","article-title":"AMIDE: a free software tool for multimodality medical image analysis","volume":"2","author":"Loening","year":"2003","journal-title":"Mol. Imag."},{"key":"10.1016\/j.ejpb.2022.08.004_b0445","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/jrr\/rrv078","article-title":"Determining organ dose conversion coefficients for external neutron irradiation by using a voxel mouse model","volume":"57","author":"Zhang","year":"2016","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.ejpb.2022.08.004_b0450","first-page":"79","article-title":"Adipose tissue density, estimated adipose lipid fraction and whole body adiposity in male cadavers","volume":"18","author":"Martin","year":"1994","journal-title":"Int. J. Obesity Related Metab. Disorders: J. Int. Assoc. Study Obesity"},{"key":"10.1016\/j.ejpb.2022.08.004_b0455","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1113\/jphysiol.1973.sp010086","article-title":"Blood volume determination in the mouse","volume":"228","author":"Riches","year":"1973","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejpb.2022.08.004_b0460","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1152\/jappl.1961.16.1.194","article-title":"Urine specific gravity and osmolality in inbred strains of mice","volume":"16","author":"Silverstein","year":"1961","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejpb.2022.08.004_b0465","unstructured":"The Mouse in Biomedical Research, Academic Press, Burlington, 2007."},{"key":"10.1016\/j.ejpb.2022.08.004_b0470","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2022.08.004_b0475","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput. Methods Programs Biomed."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641122001709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641122001709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:47:20Z","timestamp":1760546840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641122001709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":95,"alternative-id":["S0939641122001709"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.08.004","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biodistribution and toxicity of innate defense regulator 1018 (IDR-1018)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}